CGC 0.99 (-5.71%)
CA1380351009Drug ManufacturersDrug Manufacturers - Specialty & Generic

Canopy Growth (CGC) Competitor Comparison

We are evaluating the key criteria listed to compare Canopy Growth (CGC) against its competitors in the Drug Manufacturers - Specialty & Generic industry.

Linearity 3 years - CGC ranking 0 / 54

These are the competitors of Canopy Growth in the industry Drug Manufacturers - Specialty & Generic ranked by linearity 3 years
1. Supernus Pharmaceuticals SUPN
540.66
2. Phibro Animal Health PAHC
16.25
3. Evolus EOLS
15.42
4. Zoetis ZTS
14.15
5. Avadel Pharmaceuticals AVDL
12.69
6. Kolinpharma KIP.MI
11.59
7. Amphastar Pharmaceuticals AMPH
11.22
8. Alvotech ALVO
10.71
9. Kamada KMDA
9.14
10. Alimera Sciences ALIM
8.97
11. Perrigo PRGO
7.57
12. Vifor Pharma G2AB.F
6.24
13. Journey Medical DERM
5.18
14. PetIQ PETQ
5.03
15. Collegium Pharmaceutical COLL
4.01
16. Organogenesis Holdings ORGO
3.96
17. Taro Pharmaceutical Industries TARO
3.87
18. ProPhase Labs PRPH
3.8
19. Catalent CTLT
3.16
20. Linc LNC
3.15
21. Zynerba Pharmaceuticals ZYNE
3
22. Cronos Group CRON
2.94
23. Green Thumb Industries R9U2.F
2.86
24. Elanco Animal Health ELAN
2.77
25. Ironwood Pharmaceuticals IRWD
2.64
26. Curaleaf Holdings CURLF
2.56
27. OptiNose OPTN
2.55
28. Embecta EMBC
2.43
29. Societal CDMO SCTL
2.41
30. Pacira BioSciences PCRX
2.41
31. Alpha Teknova TKNO
2.3
32. Teva Pharmaceutical Industries TEVA
2.23
33. Procaps Group PROC
2.14
34. Bausch Health Companies BHC
2.07
35. Relmada Therapeutics RLMD
2.01
36. Solid Biosciences SLDB
1.99
37. Theratechnologies THTX
1.94
38. Eagle Pharmaceuticals EGRX
1.94
39. Tilray Brands TLRY
1.91
40. SCYNEXIS SCYX
1.84
41. Jupiter Wellness JUPW
1.84
42. ANI Pharmaceuticals ANIP
1.78
43. Ascend Wellness Holdings AAWH
1.76
44. Flora Growth FLGC
1.74
45. Universe Pharmaceuticals UPC
1.74
46. Biofrontera BFRI
1.68
47. Emergent BioSolutions EBS
1.63
48. Neoleukin Therapeutics NLTX
1.57
49. Clever Leaves Holdings CLVR
1.47
50. Ayr Wellness 3KJB.F
1.41
51. Cumberland Pharmaceuticals CPIX
1.36
52. Regencell Bioscience Holdings RGC
1.21
53. Amneal Pharmaceuticals AMRX
1.13
54. Harrow Health HROW
0.87

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.